Product
The following product information is for reference only by healthcare professionals. Please kindly refer to the Package Insert for more details.
HuaTangNing (华堂宁®)
Mechanism
Dorzagliatin is an ectopic allosteric glucokinase (GK) full activator, which acts on glucokinase targets in pancreatic islets, intestinal endocrine cells, liver and other glucose storage and output organs, and improves impaired glucose-stimulated insulin secretion and GLP-1 secretion in Type 2 diabetes patients, and thus improves β-cell function and reduces insulin resistance. Thereby it improves blood glucose homeostasis in patients with Type 2 diabetes, and has a mechanism of restoring the physiological regulation of blood glucose homeostasis.
【皇冠体育】
INN：Dorzagliatin Tablets
Brand Name: HuaTangNing (华堂宁®)
【皇冠体育app下载】
Active ingredients: Dorzagliatin
【皇冠体育】
Light green to green, biconvex, round film-coated tablets, debossed with "H" on one side and "75" on the other side, white or off-white after coating removal
【皇冠体育app下载】
This product is used for adults with Type 2 Diabetes Mellitus.
Monotherapy:
It can be used as mono-treatment, in parallel with diet control and exercise, to improve blood glucose control.
Combination therapy:
When metformin hydrochloride alone has poor blood glucose control, on the basis of diet control and exercise, it can be used in combination with metformin hydrochloride to improve blood glucose control.
This product is contraindicated in patients with Type 1 Diabetes Mellitus, Diabetes ketoacidosis or hyperglycemia hyperosmolality
【皇冠体育app下载】
14 tablets per blister, 28 tablets/pack
【皇冠体育】
NMPA Approval No. H20220024
Please kindly refer to the Package Insert for more details of [Usage and dosage], [Adverse reactions], [Precautions], [Combination therapy] etc.
The above information is only intended for the reference of corporate product display without any promotion purpose.
Focus Us
Copyright © 2024 Hua Medicine (Shanghai) Co., Ltd. 互联网药品信息服务资格证书编号: （沪）-非经营-2022-0079
沪ICP备14036654号-1
沪公网安备 31011502013809号 Privacy Statement Terms of Use
沪ICP备14036654号-1
沪公网安备 31011502013809号 Privacy Statement Terms of Use
Search
